Authors:
Moh’d M. Khushman, Nishant Gandhi, Joanne Xiu, Bassel El-Rayes, Andreas Seeber, Grant Richard Williams, Darryl Alan Outlaw, Emil Lou, Anthony Frank Shields, Philip Agop Philip, Wafik S. El-Deiry, John Marshall, Priya Jayachandran, Heinz-Josef Lenz, Matthew James Oberley, Wolfgang Michael Korn, Upender Manne
Key Finding:
While the prevalence of gain-of-function and non-gain-of-function TP53 mutations is higher in left-sided colorectal cancer versus right-sided, these mutations are associated with a worse median overall survival only for patients with right-sided colorectal cancer.
Download PublicationCookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |